Financials
- Market Capitalization 2.58 B
- Employee 177
- Founded 2006
- CEO N/A
- Website www.immunome.com
- Headquarter Delaware, United States
- FIGI BBG00BR93ZG8
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 1736 | IRON Disc Medicine, Inc. - Common Stock | 75.98 USD | -0.80% | -2.71% | +10.02% | +31.02% | 2.90 B USD | ||
| 1822 | QURE uniQure N.V. - Ordinary Shares | 41.10 USD | -3.59% | -1.93% | +48.11% | +181.51% | 2.59 B USD | ||
| 1829 | KOD Kodiak Sciences Inc - Common Stock | 41.10 USD | -0.51% | +9.34% | +17.80% | +675.47% | 2.57 B USD | ||
| 1836 | TARS Tarsus Pharmaceuticals, Inc. - Common Stock | 59.31 USD | +2.01% | -13.26% | -4.46% | -10.22% | 2.55 B USD |
Frequently asked questions about Immunome, Inc. - Common Stock
What is the Immunome, Inc. - Common Stock stock price today?
The current price of Immunome, Inc. - Common Stock (IMNM) is 22.8. Over the past 24 hours, the stock has changed by -2.36%. Follow the IMNM chart for real-time price dynamics.
What is the stock ticker of Immunome, Inc. - Common Stock?
Immunome, Inc. - Common Stock trades under the ticker IMNM. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Immunome, Inc. - Common Stock stock going up?
IMNM has changed by -5.00% over the last week, +22.38% over the last month, and +166.36% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Immunome, Inc. - Common Stock net income for the last quarter?
Immunome, Inc. - Common Stock reported net income of -53.84 M for the last quarter. The previous quarter showed -69.9 M, which means net income changed by +22.98%.
How many employees does Immunome, Inc. - Common Stock have?
As of the latest available data, Immunome, Inc. - Common Stock has 177 employees. Workforce size can provide additional context about the company's scale and operations.
What is Immunome, Inc. - Common Stock EBITDA?
Immunome, Inc. - Common Stock EBITDA is -53.24 M, and its EBITDA margin is -969.34%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Immunome, Inc. - Common Stock stock?
You can buy Immunome, Inc. - Common Stock (IMNM) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Immunome, Inc. - Common Stock stock?
Investing in Immunome, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the IMNM chart and related analysis on metatrader.com as part of your research.